Clinical trial
Construction of Diagnosis and Treatment System for Primary Vitreoretinal Lymphoma
NCT05950490 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Construction of Diagnosis and Treatment System for Primary Vitreoretinal Lymphoma
- Lead sponsor
- Peking Union Medical College Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 1, 2022
- Completion date
- September 30, 2025
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
primary vitreoretinal lymphoma